ZYME has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ZYME has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Zymeworks's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was $-31.65 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was $-125.97 Mil.
The historical data trend for Zymeworks's Net Income (Continuing Operations) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zymeworks Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Net Income (Continuing Operations) | Get a 7-Day Free Trial | -145.44 | -180.55 | -211.84 | 124.34 | -118.67 |
Zymeworks Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Net Income (Continuing Operations) | Get a 7-Day Free Trial | -24.35 | -51.15 | -28.69 | -14.48 | -31.65 |
Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.
Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-125.97 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zymeworks (NAS:ZYME) Net Income (Continuing Operations) Explanation
Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.
Thank you for viewing the detailed overview of Zymeworks's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul Andrew Moore | officer: Chief Scientific Officer | 114 EAST 4TH AVENUE, SUITE 800, VANCOUVER A1 V5T 1G4 |
Christopher Astle | officer: SVP & Chief Financial Officer | 114 EAST 4TH AVENUE, SUITE 800, VANCOUVER A1 V5T 1G4 |
Kenneth Galbraith | director, officer: Chair & CEO | OCEAN PARK RPO PO BOX 45025, 12851 16TH AVE, SURREY A1 V4A9L1 |
Carlos Campoy | director | 11804 NORTH CREEK PARKWAY SOUTH, BOTHELL WA 98011 |
Ecor1 Capital, Llc | 10 percent owner | 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103 |
Miller Derek John Michael | director | 108 PATRIOT DRIVE, SUITE A, 1385 WEST 8TH AVENUE, SUITE 540, MIDDLETOWN DE 19709 |
Neil A Klompas | officer: President & COO | 114 EAST 4TH AVENUE, SUITE 800, VANCOUVER A1 V5T 1G4 |
Lota S. Zoth | director | 334 CR 692, BUFFALO GAP TX 79508 |
Troy Cox | director | C/O FOUNDATION MEDICINE, INC., C/O FOUNDATION MEDICINE, INC., 150 SECON, CAMBRIDGE MA 02141 |
Kenneth J. Hillan | director | C/O ACHAOGEN, INC., 7000 SHORELINE COURT, SUITE 371, SOUTH SAN FRANCISCO CA 94080 |
Hollings Renton | director | |
Kelvin Neu | director | 860 WASHINGTON STREET, 10TH FLOOR, NEW YORK NY 10014 |
Natalie Sacks | director | C/O ADURO BIOTECH, INC., 740 HEINZ AVENUE, BERKELEY CA 94710 |
Susan Mahony | director | LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285 |
Neil Josephson | officer: Chief Medical Officer | 114 EAST 4TH AVENUE, SUITE 800, VANCOUVER A1 V5T 1G4 |
From GuruFocus
By Business Wire Business Wire • 01-04-2023
By Business Wire Business Wire • 04-17-2023
By Marketwired • 08-10-2023
By Business Wire Business Wire • 10-20-2022
By Business Wire Business Wire • 11-21-2022
By GuruFocus Research GuruFocus Editor • 12-15-2022
By GuruFocus Research • 01-09-2024
By Marketwired • 06-26-2023
By Marketwired • 08-01-2023
By Business Wire Business Wire • 12-09-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.